Patent details

Basic Information

Publication number:

EP1373300

PCT Application Number:

PCT/EP/2002/003034

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP027274372

PCT Publication Number:

WO/2002/074784

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL USE OF A PEPTIDE CLASS OF COMPOUND FOR TREATING NON NEUROPATHIC INFLAMMATORY PAIN

French Title of Invention:

NOUVELLE UTILISATION D'UNE CLASSE DE COMPOSES PEPTIDIQUES POUR LE TRAITEMENT DE DOULEURS INFLAMMATOIRES NON NEUROPATHIQUES

German Title of Invention:

VERWENDUNG EINER PEPTIDARTIGEN VERBINDUNG ZUR BEHANDLUNG VON NEUROPATHISCHEN ENTZÜNDLICHEN SCHMERZERSCHEINUNGEN

SPC Number:

91590

Dates

Filing date:

19/03/2002

Grant date:

20/05/2009

EP Publication Date:

20/05/2009

PCT Publication Date:

26/09/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/01/2004

EP B1 Publication Date:

20/05/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/03/2012

Expiration date:

19/03/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/10/2010

 

 

Name:

UCB PHARMA GMBH

Address:

ALFRED NOBEL STRASSE 10, 40789, MONHEIM, Germany (DE)

History of Owners

From:

19/03/2002

To:

26/10/2010

Name:

SCHWARZ PHARMA AG

Address:

Alfred-Nobel-Strasse 10, 40789 Monheim/Rhld., Germany (DE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

10/06/2009

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

SELVE Norma

Address:

Germany (DE)

Priority

Priority Number:

01106891

Priority Date:

20/03/2001

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07K 1/00;

Filing date	Document type	Number of pages